Research published in the European Heart Journal demonstrates that artificial intelligence can predict the risk of serious or fatal heart disease by analyzing standard mammograms. A team led by Dr. Hari Trivedi from Emory University in Atlanta discovered that AI algorithms can accurately assess the accumulation of calcium deposits in breast arteries during routine breast cancer screening. This technique offers a cost-effective method to identify cardiovascular disease in women, who are frequently underdiagnosed compared to men despite heart disease being the leading cause of death globally. The study examined data from 123,762 women who underwent breast screening with no prior known cardiovascular disease. Using AI, researchers quantified the level of arterial calcification in the breast tissue, categorizing it as absent, mild, moderate, or severe. This buildup, known as breast arterial calcification (BAC), is a sign of hardened arteries and indicates a heightened risk of heart attacks, heart failure, strokes, and cardiovascular death. The analysis revealed a direct correlation between the amount of calcification and future health risks. Women with mild calcification were approximately 30% more likely to experience a serious cardiovascular event compared to those with no calcification. The risk increased to more than 70% for those with moderate calcification and rose two to three times higher for women with severe calcification. These findings remained consistent even when accounting for other risk factors such as smoking and diabetes, and they held true for women under the age of 50, a demographic often considered low-risk. Dr. Trivedi emphasized that this study is the largest of its kind, covering diverse racial groups across two major US health systems. He noted that a standard mammogram could serve as a dual-purpose tool, providing critical information about heart health without requiring additional time, cost, or inconvenience for patients. This capability could prompt earlier conversations between patients and doctors regarding preventive measures like cholesterol testing or medication. From a public health perspective, integrating AI tools into existing mammography workflows could reach tens of millions of women annually without the need for new infrastructure. The primary requirements involve establishing clinical guidelines for reporting results and ensuring clear communication between medical providers and patients. Researchers are currently planning a clinical trial to validate these implementation steps. An accompanying editorial by Professor Lori B. Daniels from the University of California, San Diego, highlighted the potential impact of this approach. She noted that while a significant majority of women aged 50 to 69 in the European Union and nearly 70% of women aged 45 and older in the US are up to date with mammography, less than 40% report knowing their cholesterol levels. By leveraging a widely trusted cancer-screening platform, the medical community can effectively bridge this gap in cardiovascular prevention. Professor Daniels argued that it is time to shift breast arterial calcification from a passive observation to an active implementation tool to address the leading cause of death among women. The study provides compelling evidence that AI-quantified BAC is an independent marker of risk, supporting its integration into routine care to advance patient safety and prevention strategies.